News
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
What do income investors like better than a stock that pays a juicy dividend yield? The answer is easy: A stock with a juicy dividend yield that's likely to grow its dividend payout over time.
Such
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
Many stocks have been enjoying major gains as the bull market has persisted, driving up shares prices of companies across various indexes. If you're investing for the long term, what's more
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
You might think that if a drugmaker has a top-selling drug, it would be a lock to be a top-performing stock and a no-brainer buy. That may be true in some cases. In others, it can be a source of
3 High-Yield Dividend Stocks to Buy and Hold Forever
There are many reasons investors love dividends. For one, the companies that pay them are generally more stable because unhealthy companies aren't in a position to return value to shareholders in
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
If you're a retiree looking to make the most of your nest egg, putting money into dividend stocks can be a great way to do that. You can help maximize the recurring income you earn by investing in
Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts.
If you're buying a dividend stock, you need to carefully consider not just the payout ratio but also the company's long-term prospects. Intel suspended its dividend recently, an example of a
3 Fantastic Growth Stocks to Buy in August
The recent stock market sell-off appears to have fizzled out and now could be a great time for long-term investors to put some of their cash to work.
Three Motley Fool contributors think they've
This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline
If you're looking for a top healthcare company to invest in, you may want to consider looking at one that has multiple fast-growing products in its portfolio. By seeking out diversified growth
Could Viking Therapeutics Become the Next Novo Nordisk?
The much-feted biotech Viking Therapeutics (NASDAQ: VKTX) is aiming for Novo Nordisk's (NYSE: NVO) cash cow, the market for weight loss drugs. If its ambitions are fulfilled, it has a shot at
Why Pfizer Stock Slumped on Friday
In the thick of the coronavirus pandemic several years ago, any positive news from a developer of COVID-19 vaccines or drugs would have been met with a surge of buying in its stock. We're not in
How Much Will AT&T Pay Out in Dividends This Year?
AT&T (NYSE: T) stands out for its dividend with a payout that currently yields over 5.5%. That's one of the highest dividend yields in the S&P 500, where the yield is currently less than 1.5%.
A
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
The diabetes and obesity care markets are under disruption. Glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound have catapulted in popularity.
The thing
CorMedix (CRMD) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q2 2024 Earnings CallAug 14, 2024, 8:30 a.m. ET
Operator
Source Fool.com
EQS-News: Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
EQS-News: Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
According to a bullish Wall Street analyst, Abbott Laboratories (NYSE: ABT) stock could outperform for investors. Following the company's latest earnings report, Matt Miksic from Barclays maintained
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
The market is a bit jittery right now thanks to a confluence of factors, including a weaker-than-anticipated U.S. jobs report, international geopolitical issues, and foreign currency disruptions --
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With $100 Now
Would you like to improve your passive income stream but don't have a lot of extra cash to throw around? If so, I have great news: These days, $100 is all it takes to acquire a share of three top
Is Pfizer Stock a Buy Now After Earnings?
While the COVID-19 pandemic is an increasingly distant memory for most investors, Pfizer (NYSE: PFE) has struggled to move past the overhang of record vaccine sales and earnings in 2021 and 2022
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
One thing that can help with the treatment of any disease is early detection, and Alzheimer's is no exception to that. And the good news is that in the near future, detecting cases of Alzheimer's
Prediction: Rocket Lab Gets a New Neighbor in SpaceX
Five years ago -- even before its IPO -- small rocket company and SpaceX rival Rocket Lab USA (NASDAQ: RKLB) had an announcement to make.
Despite its name, Rocket Lab was primarily a New Zealand
Forget Nvidia: Buy This Magnificent Artificial Intelligence (AI) Stock Instead
There's no denying Nvidia has been the centerpiece of the artificial intelligence (AI) revolution thus far. Its technology is used in the vast majority of the world's AI platforms simply because it
3 Stocks Retirees Should Absolutely Love
Many retirees are investors for a good reason: They can't rely entirely on Social Security to fund their retirement. Investing wisely provides a means to retire comfortably.
Three Motley Fool
Agenus (AGEN) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)Q2 2024 Earnings CallAug 08, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Geron (GERN) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Geron (NASDAQ: GERN)Q2 2024 Earnings CallAug 08, 2024, 8:00 a.m. ET
Operator
Source Fool.com